6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole → HCID 71765545, compound

HRID 2203230Notes

Reaction equation

HRID 2203230 reaction equation
CC1(C)C(C)(C)OB([C:9]2[CH:17]=[C:16]3[C:12]([CH:13]=[N:14][NH:15]3)=[CH:11][CH:10]=2)O1.[NH2:19][C:20]1[C:29]2[C:24](=[C:25](Br)[C:26]([CH2:30][CH3:31])=[CH:27][CH:28]=2)[N:23]=[N:22][C:21]=1[C:33]([NH2:35])=[O:34]>>[NH2:19][C:20]1[C:29]2[C:24](=[C:25]([C:9]3[CH:17]=[C:16]4[C:12]([CH:13]=[N:14][NH:15]4)=[CH:11][CH:10]=3)[C:26]([CH2:30][CH3:31])=[CH:27][CH:28]=2)[N:23]=[N:22][C:21]=1[C:33]([NH2:35])=[O:34]

Participants

3

Reactant 2

HCID 441192506-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazoleHCID 89825402HCID 89825402, compound

Product 1

HCID 71765545HCID 71765545, compound

Procedure

The title compound was prepared in a manner similar to EXAMPLE 1 using 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole and 4-amino-8-bromo-7-ethylcinnoline-3-carboxamide. ESI-MS m/z [M+H]+ 333.

Sources & evidence

ORD record
ord-13d80c35604a4f5ebeab8f3852ebed10
Source dataset
uspto-grants-2016_06
Patent number
US09365566B2

Reaction notes

Loading…